(Q40635730)

22 September 2017

1 reference

title

Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine (English)

1 reference

22 September 2017

0 references

1 reference

Ling W

1

1 reference

22 September 2017

Rawson RA

series ordinal

2

1 reference

22 September 2017

Compton MA

series ordinal

3

1 reference

22 September 2017

publication date

1 April 1994

1 reference

Journal of Psychoactive Drugs

22 September 2017

published in

1 reference

22 September 2017

volume

26

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

119-128

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

22 September 2017

1 reference

Methadone Treatment of Randomly Selected Criminal Addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

AIDS and addiction in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Mortality in heroin addiction: impact of methadone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

"It takes your heart": the image of methadone maintenance in the addict world and its effect on recruitment into treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

A controlled trial of buprenorphine treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Treatment of cocaine abuse with buprenorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

A cooperative clinical study of methadyl acetate. I. Three-times-a-week regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Buprenorphine suppresses heroin use by heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Affinities of some common opioid analgesics towards four binding sites in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Untreated opiate addicts. How do they differ from those seeking treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Assessment and management of opioid withdrawal symptoms in buprenorphine‐dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Methadone/LAAM maintenance: a comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Methadyl acetate and methadone. An open comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

The use of l-alpha-acetylmethadol in treatment of heroin addiction: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.1994.10472259

10.1080/02791072.1994.10472259

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference